• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植物化学物质对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)木瓜样蛋白酶(PLpro)的蛋白水解和去泛素酶活性的抑制作用。

Inhibitory effect of phytochemicals towards SARS-CoV-2 papain like protease (PLpro) proteolytic and deubiquitinase activity.

作者信息

Kawall Anasha, Lewis Devin S M, Sharma Avini, Chavada Krishna, Deshmukh Rahul, Rayalam Srujana, Mody Vicky, Taval Shashidharamurthy

机构信息

Department of Biomedical Sciences, Philadelphia College of Osteopathic Medicine-Georgia Campus, Suwanee, GA, United States.

Division of Research, Philadelphia College of Osteopathic Medicine-Georgia Campus, Suwanee, GA, United States.

出版信息

Front Chem. 2023 Jan 12;10:1100460. doi: 10.3389/fchem.2022.1100460. eCollection 2022.

DOI:10.3389/fchem.2022.1100460
PMID:36712981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9878345/
Abstract

Recent studies have shown that RNA-dependent RNA polymerase (RdRp), 3-chymotrypsin-like protease (3CLpro), and papain-like protease (PLpro) are necessary for SARS-CoV-2 replication. Among these three enzymes, PLpro exhibits both proteolytic and deubiquitinase (DUB) activity and is responsible for disrupting the host's innate immune response against SARS-CoV-2. Because of this unique property of PLpro, we investigated the inhibitory effects of phytochemicals on the SARS-CoV-2 PLpro enzyme. Our data indicates that the phytochemicals such as catechin, epigallocatechin gallate (EGCG), mangiferin, myricetin, rutin, and theaflavin exhibited inhibitory activity with IC values of 14.2, 128.4, 95.3, 12.1, and 43.4, and 7.3 μM, respectively, towards PLpro proteolytic activity. However, the IC values of quercetin, oleuropein, and γ-mangostin are ambiguous. We observed that EGCG, mangiferin, myricetin, oleuropein, rutin, and theaflavin have also inhibited the DUB activity with IC values of 44.7, 104.3, 29.2, 131.5, 61.7, and 13.2 μM, respectively. Mechanistically, the ligand-protein interaction structural modeling suggests that mangiferin, EGCG, theaflavin, and oleuropein shows that these four ligands interact with Glu, and Tyr, however mangiferin and oleuropein showed very weak interaction with Glu as compared to EGCG, and theaflavin which reflects their low IC values for DUB activity. Our data indicate that the phytochemicals mentioned above inhibit the proteolytic and DUB activity of SARS-CoV-2 PLpro, thus preventing viral replication and promoting host innate immune response. However, the therapeutic potential of these phytochemicals needs to be validated by pre-clinical and clinical studies.

摘要

最近的研究表明,RNA依赖的RNA聚合酶(RdRp)、3-糜蛋白酶样蛋白酶(3CLpro)和木瓜蛋白酶样蛋白酶(PLpro)对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的复制是必需的。在这三种酶中,PLpro兼具蛋白水解和去泛素酶(DUB)活性,并负责破坏宿主针对SARS-CoV-2的固有免疫反应。由于PLpro的这种独特特性,我们研究了植物化学物质对SARS-CoV-2 PLpro酶的抑制作用。我们的数据表明,儿茶素、表没食子儿茶素没食子酸酯(EGCG)、芒果苷、杨梅素、芦丁和茶黄素等植物化学物质对PLpro蛋白水解活性表现出抑制活性,其IC值分别为14.2、128.4、95.3、12.1、43.4和7.3μM。然而,槲皮素、橄榄苦苷和γ-山竹黄酮的IC值不明确。我们观察到,EGCG、芒果苷、杨梅素、橄榄苦苷、芦丁和茶黄素也抑制了DUB活性,其IC值分别为44.7、104.3、29.2、131.5、61.7和13.2μM。从机制上讲,配体-蛋白质相互作用结构建模表明,芒果苷、EGCG、茶黄素和橄榄苦苷显示这四种配体与Glu和Tyr相互作用,然而与EGCG和茶黄素相比,芒果苷和橄榄苦苷与Glu的相互作用非常弱,这反映了它们对DUB活性的低IC值。我们的数据表明,上述植物化学物质抑制SARS-CoV-2 PLpro的蛋白水解和DUB活性,从而阻止病毒复制并促进宿主固有免疫反应。然而,这些植物化学物质的治疗潜力需要通过临床前和临床研究来验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/821f326626c8/fchem-10-1100460-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/0fe1b1ae1946/FCHEM_fchem-2022-1100460_wc_abs.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/1644faa7d7e6/fchem-10-1100460-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/530de189ef40/fchem-10-1100460-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/b5d41acb3cae/fchem-10-1100460-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/3de4dfb97376/fchem-10-1100460-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/a08a0d70d437/fchem-10-1100460-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/5e108fa404a3/fchem-10-1100460-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/6d06f049a369/fchem-10-1100460-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/821f326626c8/fchem-10-1100460-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/0fe1b1ae1946/FCHEM_fchem-2022-1100460_wc_abs.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/1644faa7d7e6/fchem-10-1100460-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/530de189ef40/fchem-10-1100460-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/b5d41acb3cae/fchem-10-1100460-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/3de4dfb97376/fchem-10-1100460-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/a08a0d70d437/fchem-10-1100460-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/5e108fa404a3/fchem-10-1100460-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/6d06f049a369/fchem-10-1100460-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0e/9878345/821f326626c8/fchem-10-1100460-g008.jpg

相似文献

1
Inhibitory effect of phytochemicals towards SARS-CoV-2 papain like protease (PLpro) proteolytic and deubiquitinase activity.植物化学物质对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)木瓜样蛋白酶(PLpro)的蛋白水解和去泛素酶活性的抑制作用。
Front Chem. 2023 Jan 12;10:1100460. doi: 10.3389/fchem.2022.1100460. eCollection 2022.
2
Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro.芦荟异构体(A 和 B)在体外选择性抑制 SARS-CoV-2 的木瓜蛋白酶样蛋白酶(PLpro)的蛋白水解和去泛素化活性。
Sci Rep. 2022 Feb 9;12(1):2145. doi: 10.1038/s41598-022-06104-y.
3
Black tea bioactives as inhibitors of multiple targets of SARS-CoV-2 (3CLpro, PLpro and RdRp): a virtual screening and molecular dynamic simulation study.红茶生物活性成分抑制 SARS-CoV-2 的多个靶点(3CLpro、PLpro 和 RdRp):虚拟筛选和分子动力学模拟研究。
J Biomol Struct Dyn. 2022 Sep;40(15):7143-7166. doi: 10.1080/07391102.2021.1897679. Epub 2021 Mar 10.
4
Therapeutic potential of green tea catechin, (-)-epigallocatechin-3--gallate (EGCG) in SARS-CoV-2 infection: Major interactions with host/virus proteases.绿茶儿茶素(-)-表没食子儿茶素-3-没食子酸酯(EGCG)在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染中的治疗潜力:与宿主/病毒蛋白酶的主要相互作用
Phytomed Plus. 2023 Feb;3(1):100402. doi: 10.1016/j.phyplu.2022.100402. Epub 2022 Dec 30.
5
Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.中东呼吸综合征冠状病毒木瓜蛋白酶样蛋白酶的蛋白水解加工、去泛素化酶和干扰素拮抗活性。
J Gen Virol. 2014 Mar;95(Pt 3):614-626. doi: 10.1099/vir.0.059014-0. Epub 2013 Dec 20.
6
Characterization of the Ubiquitin and ISG15 Deconjugase Activity of SARS-CoV-1 and SARS-CoV-2 Papain-Like Protease.严重急性呼吸综合征冠状病毒1型和2型木瓜蛋白酶样蛋白酶的泛素及ISG15去结合酶活性的表征
Methods Mol Biol. 2023;2591:171-188. doi: 10.1007/978-1-0716-2803-4_11.
7
Deubiquitinating activity of SARS-CoV-2 papain-like protease does not influence virus replication or innate immune responses in vivo.SARS-CoV-2 木瓜蛋白酶样蛋白酶的去泛素化活性不会影响病毒在体内的复制或先天免疫反应。
PLoS Pathog. 2024 Mar 25;20(3):e1012100. doi: 10.1371/journal.ppat.1012100. eCollection 2024 Mar.
8
Potent, Novel SARS-CoV-2 PLpro Inhibitors Block Viral Replication in Monkey and Human Cell Cultures.强效新型SARS-CoV-2木瓜蛋白酶样蛋白酶(PLpro)抑制剂可阻断猴和人细胞培养物中的病毒复制。
bioRxiv. 2021 Feb 15:2021.02.13.431008. doi: 10.1101/2021.02.13.431008.
9
Screening of phytochemicals as potent inhibitor of 3-chymotrypsin and papain-like proteases of SARS-CoV2: an in silico approach to combat COVID-19.利用计算机模拟方法筛选可有效抑制 SARS-CoV2 3 型糜蛋白酶和木瓜蛋白酶样蛋白酶的植物化学物质以对抗 COVID-19。
J Biomol Struct Dyn. 2022 Mar;40(5):2067-2081. doi: 10.1080/07391102.2020.1835729. Epub 2020 Oct 22.
10
Targeting papain-like protease by natural products as novel therapeutic potential SARS-CoV-2.天然产物靶向木瓜蛋白酶样蛋白酶作为新型治疗 SARS-CoV-2 的潜在靶点。
Int J Biol Macromol. 2024 Feb;258(Pt 1):128812. doi: 10.1016/j.ijbiomac.2023.128812. Epub 2023 Dec 17.

引用本文的文献

1
Inhibitory effects of senkyuchachosan on SARS-CoV-2 papain-like protease activity in vitro.汉防己甲素对 SARS-CoV-2 木瓜蛋白酶样蛋白酶活性的体外抑制作用。
J Nat Med. 2024 Jun;78(3):784-791. doi: 10.1007/s11418-024-01788-0. Epub 2024 Mar 21.
2
Identification of Phytochemicals from Arabian Peninsula Medicinal Plants as Strong Binders to SARS-CoV-2 Proteases (3CL and PL) by Molecular Docking and Dynamic Simulation Studies.通过分子对接和动态模拟研究鉴定来自阿拉伯半岛药用植物的植物化学物质作为 SARS-CoV-2 蛋白酶(3CL 和 PL)的强结合物。
Molecules. 2024 Feb 25;29(5):998. doi: 10.3390/molecules29050998.

本文引用的文献

1
Oral GS-441524 derivatives: Next-generation inhibitors of SARS-CoV-2 RNA-dependent RNA polymerase.口服 GS-441524 衍生物:新一代 SARS-CoV-2 依赖 RNA 的 RNA 聚合酶抑制剂。
Front Immunol. 2022 Dec 6;13:1015355. doi: 10.3389/fimmu.2022.1015355. eCollection 2022.
2
Bioactive natural products in COVID-19 therapy.用于新冠治疗的生物活性天然产物。
Front Pharmacol. 2022 Aug 19;13:926507. doi: 10.3389/fphar.2022.926507. eCollection 2022.
3
Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease.
天然酚类化合物在 SARS-CoV-2 木瓜蛋白酶样蛋白酶变构位点复合物中的抗病毒活性。
Commun Biol. 2022 Aug 11;5(1):805. doi: 10.1038/s42003-022-03737-7.
4
Post-acute Sequelae of SARS-CoV-2 Infection: A Neglected Public Health Issue.新型冠状病毒感染的急性后遗症:一个被忽视的公共卫生问题。
Front Public Health. 2022 Jun 17;10:908757. doi: 10.3389/fpubh.2022.908757. eCollection 2022.
5
From Positive to Negative to Positive Again-The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid.从阳性到阴性再到阳性——服用帕罗韦德的部分新冠患者病情反弹之谜
JAMA. 2022 Jun 28;327(24):2380-2382. doi: 10.1001/jama.2022.9925.
6
Inhibitors of SARS-CoV-2 PLpro.严重急性呼吸综合征冠状病毒2型木瓜蛋白酶样蛋白酶(SARS-CoV-2 PLpro)抑制剂
Front Chem. 2022 Apr 26;10:876212. doi: 10.3389/fchem.2022.876212. eCollection 2022.
7
A review on potential of natural products in the management of COVID-19.天然产物在新冠病毒疾病管理中的潜力综述。
RSC Adv. 2021 May 12;11(27):16711-16735. doi: 10.1039/d1ra00644d. eCollection 2021 Apr 30.
8
Molnupiravir and Nirmatrelvir-Ritonavir: Oral Coronavirus Disease 2019 Antiviral Drugs.莫努匹韦和奈玛特韦-利托那韦:口服冠状病毒病 2019 抗病毒药物。
Clin Infect Dis. 2023 Jan 6;76(1):165-171. doi: 10.1093/cid/ciac180.
9
Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review.奥密克戎的遗传和临床特征可能颠覆 SARS-CoV-2 大流行:文献综述。
Int J Mol Sci. 2022 Feb 11;23(4):1987. doi: 10.3390/ijms23041987.
10
Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses.抗击 SARS-CoV-2 大流行需要采取全球方法来了解疫苗反应的异质性。
Nat Immunol. 2022 Mar;23(3):360-370. doi: 10.1038/s41590-022-01130-4. Epub 2022 Feb 24.